Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2025-07-30 Governance Information
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
对外担保管理制度（2025年7月修订）
Governance Information Classification · 95% confidence The document is titled as a management system for external guarantees by the company, detailing internal rules, approval procedures, responsibilities, and disclosure obligations related to external guarantees. It is a governance-related document focusing on company policies and procedures rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of it being an annual report, audit report, earnings release, or any other financial statement. It is not a regulatory filing or announcement but a detailed internal governance document. Therefore, the most appropriate classification is Governance Information (CGR). The document length (6149 characters) supports it being a full policy document rather than a brief announcement.
2025-07-30 Chinese
对外投资管理制度（2025年7月修订）
Governance Information Classification · 95% confidence The document is titled '益丰大药房连锁股份有限公司 对外投资管理制度' which translates to 'Yifeng Pharmacy Chain Co., Ltd. External Investment Management System'. It is a detailed internal policy document outlining the principles, approval authorities, roles, execution controls, investment disposal, and supervision related to the company's external investment activities. It includes references to company law, internal governance, and procedural controls but does not contain financial statements, audit results, or financial performance data. It is not an announcement, report, or regulatory filing but an internal governance or management policy document. Therefore, it best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-07-30 Chinese
独立董事工作制度（2025年7月修订）
Governance Information Classification · 95% confidence The document is titled '益丰大药房连锁股份有限公司 独立董事工作制度' which translates to 'Independent Director Work System of Yifeng Pharmacy Chain Co., Ltd.' It details the rules, responsibilities, qualifications, and procedures related to independent directors of the company. The content focuses on governance structure, director duties, nomination, election, and independence criteria. There is no financial data, earnings information, or report publication announcement. The document is a governance-related policy document outlining internal rules and practices for independent directors. Therefore, it fits best under Governance Information (CGR). The document length (6462 characters) and detailed content support this classification with high confidence.
2025-07-30 Chinese
董事会议事规则（2025年7月修订）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors' of 益丰大药房连锁股份有限公司. The content extensively details the structure, duties, responsibilities, meeting procedures, and governance of the company's board of directors. It includes sections on the general principles, directors' duties, independent directors, board powers, meeting protocols, and archival rules. There is no financial data, audit information, or report on company performance. Instead, it focuses on governance practices and internal rules related to the board. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial (over 11,000 characters), indicating it is the full governance document, not just an announcement or summary.
2025-07-30 Chinese
董事、高级管理人员离职制度（2025年7月）
Board/Management Information Classification · 95% confidence The document is titled as a management system or policy regarding the resignation and departure management of directors and senior management personnel of the company. It details procedures, responsibilities, obligations, and restrictions related to the departure of board members and senior executives. There is no financial data, no financial results, no earnings information, no voting results, no capital changes, no legal proceedings, no audit information, and no presentation or report publication announcement. The content is focused on governance and management rules concerning board and senior management personnel changes. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements or information about changes in the company's board or senior management.
2025-07-30 Chinese
防范控股股东及关联方占用公司资金制度（2025年7月修订）
Governance Information Classification · 95% confidence The document is a formal policy titled '防范控股股东及关联方占用公司资金制度' (Prevention of Controlling Shareholders and Related Parties from Occupying Company Funds System) approved by the company's board of directors. It outlines internal governance rules and procedures to prevent misuse of company funds by controlling shareholders and related parties. The document is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and responsibilities of the board and management regarding fund safety and related party transactions. The document length is about 2024 characters, indicating it is a full policy document rather than a brief announcement. Therefore, the most appropriate classification is Governance Information (CGR).
2025-07-30 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.